High pulse pressure linked to OAG

Article

High-tension open angle glaucoma (htOAG) is associated with high pulse pressure, increased carotid arterial stiffness and, in people treated for systemic hypertension, low diastolic perfusion pressure.

High-tension open angle glaucoma (htOAG) is associated with high pulse pressure, increased carotid arterial stiffness and, in people treated for systemic hypertension, low diastolic perfusion pressure, according to a report published in the June issue of Archives of Ophthalmology.

Caroline Hulsman and colleagues from The Netherlands Institute for Neuroscience conducted a study to investigate cross-sectional associations among blood pressures (BPs), arterial stiffness and open angle glaucoma (OAG). Participants were recruited from the population-based Rotterdam Study. Subjects were classified as either htOAG or normal tension OAG (ntOAG), according to an intraocular pressure (IOP) of greater than, or less than 21 mmHg. Pulse pressure was defined as the difference between systolic and diastolic BP, while diastolic perfusion pressure was defined as the difference between diastolic BP and IOP.

A total of 5,317 subjects were included in the study. In subjects with higher pulse pressure, the prevalence of htOAG was elevated. In those who were treated for systemic hypertension, low diastolic perfusion pressure (<50 mmHg) was inversely associated with ntOAG and positively associated with htOAG.

It was concluded that htOAG is particularly associated with high pulse pressure.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.